Suppr超能文献

在新兴经济体国家建立自体与异体造血细胞移植项目。

Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies.

作者信息

Chaudhri Naeem A, Aljurf Mahmoud, Almohareb Fahad I, Alzahrani Hazzaa A, Bashir Qaiser, Savani Bipin, Gupta Vikas, Hashmi Shahrukh K

机构信息

Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

出版信息

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):173-177. doi: 10.1016/j.hemonc.2017.05.016. Epub 2017 Jul 3.

Abstract

More than 70,000 hematopoietic cell transplants are currently performed each year, and these continue to increase every year. However, there is a significant variation in the number of absolute transplants and transplant rates between centers, countries, and global regions. The prospect for emerging countries to develop a hematopoietic cell transplantation (HCT) program, as well as to decide on whether autologous HCT (auto-HCT) or allogeneic HCT (allo-HCT) should be established to start with, relies heavily on factors that can explain differences between these two procedures. Major factors that will influence a decision about establishing the type of HCT program are macroeconomic factors such as organization of the healthcare network, available resources and infrastructure. Prevalence of specific diseases in the region as well genetic background of donors and recipients will also influence the mandate or priority of the HCT in the national healthcare plan to explain some of the country-specific differences. Furthermore, microeconomic factors play a role, such as center-specific experience in treating various disorders requiring hematopoietic stem cell transplantation, along with accreditation status and patient volume. The objective of the transplant procedure was to improve the survival and quality of life of patients. The regional difference that one notices in emerging countries about the higher number of allo-HCT compared with auto-HCT procedures performed is primarily based on suboptimal healthcare network in treating various malignant disorders that are the primary indication for auto-stem cell transplantation. In this context, nonmalignant disorders such as bone marrow failure syndromes, inherited genetic disorders and hemoglobinopathies have become the major indication for stem cell transplantation. Better understanding of these factors will assist in establishing new transplant centers in the emerging countries to achieve their specific objectives and positive outcome.

摘要

目前,每年进行的造血细胞移植超过7万例,且这一数字还在逐年增加。然而,各中心、国家和全球区域之间的绝对移植数量和移植率存在显著差异。新兴国家发展造血细胞移植(HCT)项目,以及决定首先应建立自体HCT(auto-HCT)还是异基因HCT(allo-HCT),在很大程度上依赖于能够解释这两种程序差异的因素。影响决定建立何种类型HCT项目的主要因素是宏观经济因素,如医疗保健网络的组织、可用资源和基础设施。该地区特定疾病的患病率以及供体和受体的遗传背景也将影响国家医疗保健计划中HCT的任务或优先级,以解释一些国家特有的差异。此外,微观经济因素也起作用,如各中心在治疗各种需要造血干细胞移植的疾病方面的经验,以及认证状态和患者数量。移植程序的目标是提高患者的生存率和生活质量。在新兴国家,人们注意到allo-HCT的数量高于auto-HCT程序,这种地区差异主要是基于在治疗各种恶性疾病(自体干细胞移植的主要适应症)方面次优的医疗保健网络。在这种情况下,骨髓衰竭综合征、遗传性遗传疾病和血红蛋白病等非恶性疾病已成为干细胞移植的主要适应症。更好地理解这些因素将有助于在新兴国家建立新的移植中心,以实现其特定目标和取得积极成果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验